Evidence map›Paper›PMID 29043120›Full record

ArticleClinical nephrology. Case studies2013

Is there a pathogenic association between Fabry's disease and IgA nephropathy?

Shuichiro Fujinaga, Hitohiko Murakami, Mitsuru Kubota, Hiroshi Mochizuki, Toshiaki Shimizu

Open access · greenAbstract readCase Reports
In one paragraph

Article in Clinical nephrology. Case studies, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shuichiro FujinagaDivision of Nephrology, Saitama Children's Medical Center.
Hitohiko MurakamiDivision of Pathology, Saitama Children's Medical Center.
Mitsuru KubotaDivision of General Pediatrics, Saitama Children's Medical Center.
Hiroshi MochizukiDivision of Metabolism and Endocrinology, Saitama Children's Medical Center, Saitama-city Saitama, and.
Toshiaki ShimizuDepartment of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan.
Saitama Children's Medical Center · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several cases of concurrent Fabry's disease and IgA nephropathy have been reported, but the pathogenic association between these two diseases remains unclear. This is a report on the case of a girl with severe IgA nephropathy who was subsequently diagnosed with subclinical Fabry's disease. An 11-year-old girl was admitted to our hospital with massive proteinuria and hematuria detected by urinary screening. An initial renal biopsy revealed severe IgA nephropathy with diffuse mesangial proliferation. She was treated with intravenous methylprednisolone pulses followed by 2 years of oral steroids. The treatment improved both the urinary abnormalities and the second renal biopsy findings. At the age of 15 years, mild proteinuria prompted us to perform a third renal biopsy, and histology revealed minor glomerular abnormalities. In addition, numerous myelin-like bodies were detected in podocytes by electron microscopy. The histological findings combined with the low level of α-galactosidase A activity led to the diagnosis of concomitant Fabry's disease with IgA nephropathy. Our experience suggests that the initial massive proteinuria was not due to Fabry's disease, but was rather a manifestation of coincidental IgA nephropathy. We speculate that the coexistence of IgA nephropathy and Fabry's disease occurred by chance.

Indexed as

Fabry’s diseaseIgA nephropathy

Identifiers

PMID29043120
PMCPMC5437989
OpenAlexW2315455084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.